MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Semantic Memory Deficit as a Potential Risk Factor of Dementia in Isolated Rapid Eye Movement Sleep Behavior Disorder

    C. Zigrand, M. Trepanier Maurais, R. Postuma, S. Joubert, I. Rouleau, JF. Gagnon (Montreal, Canada)

    Objective: We aimed to evaluate semantic memory (SM) performance in isolated/idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) and identify the specific profile of…
  • 2025 International Congress

    The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

    A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)

    Objective: The scope of this work was to characterise the B-cell receptor repertoire of patients with Parkinson’s disease with dementia (PDD), cognitively resilient (PDR) and…
  • 2025 International Congress

    Cognitive Assessment in Parkinson’s Disease: A Mixed Methods Study of Current Neuropsychology Practices in Australia

    J. King, D. Pourzinal, J. Yang, D. Brooks, D. Sriram, K. Sivakumaran, L. Mitchell, N. Dissanayaka (HERSTON, Australia)

    Objective: To investigate the role of neuropsychologists, and their current practices for assessing cognition in Parkinson’s disease (PD). Background: Diagnosis and evaluation of cognitive disorders…
  • 2025 International Congress

    Caution in the creation of Parkinson’s disease cognitive composites

    D. Gonzalez, A. Karstens, J. Fleisher, S. Patel, C. Goetz (Chicago, USA)

    Objective: To evaluate the structural validity of new cognitive composites in Parkinson’s disease (PCCs). Background: PCCs created from constituent tasks are promising in their single-index…
  • 2025 International Congress

    Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson’s Disease – A Randomized, Placebo-Controlled Trial (Short Title: ProD)

    A. Lemkow, A. Kuan, J. Lam, F. Vila-Rodriguez, M. Mckeown, J. Squires, A. Howard, S. Appel-Cresswell (Vancouver, Canada)

    Objective: Objective: To assess the impact of probiotic supplementation on depression symptoms and the gut microbiome in people living with Parkinson’s disease (PwPD). Background: Background:…
  • 2025 International Congress

    Ventral and Dorsal Language Pathways in Patients with Lewy Bodies: an fMRI Study of Syntactic Sentence Processing

    L. Novakova, M. Gajdos, D. Carbol, I. Rektorova (Brno, Czech Republic)

    Objective: Aim of this study is to describe specific alterations in comprehending syntactically complex sentences in patients with Lewy body diseases (LBDs) that already have…
  • 2025 International Congress

    Time for a digital clock?

    T. Turner, S. Crowley (Charleston, USA)

    Objective: Evaluate an automated digital tool for administering and scoring the Clock Drawing Test (CDT) in a movement disorders clinic. Background: The CDT is a…
  • 2025 International Congress

    Diagnostic and Treatment Delays in Normal Pressure Hydrocephalus: A Retrospective Analysis at a Tertiary Care Center

    S. Chawla, P. Gupta, T. Liang (Philadelphia, USA)

    Objective: To identify and evaluate critical points of delay in the diagnosis and treatment of normal pressure hydrocephalus (NPH) at a tertiary care center. Background:…
  • 2025 International Congress

    Cognitive Improvement in Parkinson’s Disease Patients After Intravenous Mesenchymal Stem Cell Infusion: Results from a Phase 2 Randomized Trial

    T. Thomas, J. Martinez-Lemus, E. Tharp, C. Green, C. Onuigbo, J. Suescun, T. Le, E. Rodarte Rascon, R. Ritter Iii, T. Ellmore, M. Schiess (Houston, USA)

    Objective: Assess the impact of treatment with intravenous (IV) allogeneic bone marrow-derived mesenchymal stem cells (allo-hMSCs) on cognition in patients with mild-moderate Parkinson’s Disease (PD).…
  • 2025 International Congress

    Aberrations in Voluntary Thought Initiation: Parallels to Motor Freezing in Basal Ganglia Dysfunction

    S. Shugar, N. Choudhury, D. Nolasco, B. Carr (Gainesvile, USA)

    Objective: To explore the neurophysiological basis of impaired volitional thought initiation focusing on dorsal caudate dysfunction, aberrant pallidal-thalamic inhibition, and impaired corticostriatal integration. Background: While…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley